Who
Hila Karah
Director
Company insider
Files Form 4 as: Director, DarioHealth; Director, Indaptus Therapeutics; Director, Cyren; Director, Intec Pharma.
In numbers
- Trades disclosed
- 46
- Buys
- 11
- Sells
- 0
- Bought
- $14K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 4 Mar 2016
- Last trade
- 24 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 28 Sep 2026 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 11 Sep 2025filed 15 Sep 2025 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 10 Jun 2025filed 11 Jun 2025 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 10 Apr 2025filed 11 Apr 2025 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | $195500 at $0.39 | filing |
| 10 Apr 2025filed 11 Apr 2025 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | $98250 at $0.39 | filing |
| 10 Apr 2025filed 11 Apr 2025 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | $110281 at $0.39 | filing |
| 10 Apr 2025filed 11 Apr 2025 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | $98250 at $0.39 | filing |
| 6 Jun 2024filed 7 Jun 2024 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 6 Mar 2024filed 8 Mar 2024 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 25 May 2023filed 30 May 2023 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 30 Sep 2022filed 3 Oct 2022 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,750 at $0.00 | filing |
| 22 Sep 2022filed 26 Sep 2022 | Cyren | SEC FORM 4 Code A | $21K17,500 at $1.18 | filing |
| 18 May 2022filed 20 May 2022 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 4 Aug 2021filed 6 Aug 2021 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,750 at $0.00 | filing |
| 21 Jul 2021filed 23 Jul 2021 | Cyren | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 19 Jan 2021filed 21 Jan 2021 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —20,147 at $0.00 | filing |
| 4 Jan 2021filed 6 Jan 2021 | Cyren | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 16 Oct 2020filed 20 Oct 2020 | DRIO DarioHealthMedical Devices | SEC FORM 4 Bought | —1,372 at $0.00 | filing |
| 20 Jul 2020filed 22 Jul 2020 | DRIO DarioHealthMedical Devices | SEC FORM 4 Bought | —2,378 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.